Literature DB >> 9561379

Correlation between plasma levels of cytokines and HIV-1 RNA copy number in HIV-infected patients.

G Hittinger1, C Poggi, E Delbeke, N Profizi, A Lafeuillade.   

Abstract

The plasma levels of HIV-1 RNA, tumor necrosis factor alpha (TNF-alpha), soluble receptors type II of TNF-alpha (sTNF-alpha RII), soluble receptors of interleukin-4 (sR IL-4), interleukin-6 (IL-6), soluble receptors of interleukin-6 (sR IL-6), granulocyte macrophage colony stimulating factor (GM-CSF), soluble receptors of GM-CSF (sR GM-CSF), RANTES, MIP-1 alpha and MIP-1 beta were measured in 80 HIV-infected patients. All patients had not been treated previously with antiretroviral drugs and did not present a recent history of opportunistic infection. A statistically significant correlation was found between HIV-1 RNA and TNF-alpha (p = 0.005) or sTNF-alpha RII levels (p < 0.001). RANTES and MIP-1 alpha levels did not correlate with HIV-1 RNA. MIP-1 beta levels were correlated with plasma RNA titers in patients with CD4+ T cells < 200 x 10(6)/l (p = 0.03). MIP-1 alpha and sR IL-4 levels were significantly different according to the CD4+ T cell range (p = 0.003 and p = 0.0002, respectively). GM-CSF and sR GM-CSF were undetectable in each case. These data confirm that HIV-1 replication in the plasma is correlated with TNF-alpha levels, but do not show a clear correlation with levels of the chemokines studied.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9561379     DOI: 10.1007/BF02767768

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  23 in total

1.  Inhibition of immunoreactive tumor necrosis factor-alpha by a chimeric antibody in patients infected with human immunodeficiency virus type 1.

Authors:  R E Walker; K M Spooner; G Kelly; R V McCloskey; J N Woody; J Falloon; M Baseler; S C Piscitelli; R T Davey; M A Polis; J A Kovacs; H Masur; H C Lane
Journal:  J Infect Dis       Date:  1996-07       Impact factor: 5.226

2.  Cytokines and soluble receptor changes in the transition from primary to early chronic HIV type 1 infection.

Authors:  W Barcellini; G P Rizzardi; G Poli; G Tambussi; C Velati; P L Meroni; A G Dalgleish; A Lazzarin
Journal:  AIDS Res Hum Retroviruses       Date:  1996-03-01       Impact factor: 2.205

3.  Immunocytochemical localization of the chemokines RANTES and MIP-1 alpha within human platelets and their release during storage.

Authors:  M H Klinger; D Wilhelm; S Bubel; M Sticherling; J M Schröder; W Kühnel
Journal:  Int Arch Allergy Immunol       Date:  1995-08       Impact factor: 2.749

4.  AIDS conference. Chemokines share center stage with drug therapies.

Authors:  J Cohen
Journal:  Science       Date:  1996-07-19       Impact factor: 47.728

5.  Serum levels of RANTES and MIP-1 alpha in HIV-positive long-term survivors and progressor patients.

Authors:  S Zanussi; M D'Andrea; C Simonelli; U Tirelli; P De Paoli
Journal:  AIDS       Date:  1996-10       Impact factor: 4.177

6.  RANTES, MIP and interleukin-16 in HIV infection.

Authors:  V Blazevic; M Heino; A Ranki; T Jussila; K J Krohn
Journal:  AIDS       Date:  1996-10       Impact factor: 4.177

7.  Does zidovudine reduce tumour necrosis factor-alpha in HIV-positive patients?

Authors:  L Cremoni; L L Vaira; P D'Amico; M G Grassi; F Milazzo
Journal:  AIDS       Date:  1993-01       Impact factor: 4.177

8.  Macrophage inflammatory protein-1 alpha rapidly modulates its receptors and inhibits the anti-CD3 mAb-mediated proliferation of T lymphocytes.

Authors:  Z Zhou; Y J Kim; K Pollok; J Hurtado; J K Lee; H E Broxmeyer; B S Kwon
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

Review 9.  The role of MIP-1 alpha in inflammation and hematopoiesis.

Authors:  D N Cook
Journal:  J Leukoc Biol       Date:  1996-01       Impact factor: 4.962

10.  Tumour necrosis factors (alpha, beta) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication.

Authors:  A Vyakarnam; J McKeating; A Meager; P C Beverley
Journal:  AIDS       Date:  1990-01       Impact factor: 4.177

View more
  14 in total

1.  Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status.

Authors:  A Garzino-Demo; R B Moss; J B Margolick; F Cleghorn; A Sill; W A Blattner; F Cocchi; D J Carlo; A L DeVico; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

2.  Decreases in plasma TNF-alpha level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients.

Authors:  P Brazille; N Dereuddre-Bosquet; C Leport; P Clayette; O Boyer; J-L Vildé; D Dormont; O Benveniste
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

Review 3.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

Review 4.  Bone and vitamin D metabolism in HIV.

Authors:  Aristotle Panayiotopoulos; Nandini Bhat; Amrit Bhangoo
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

5.  Soluble tumor necrosis factor alpha receptors (sTNF-Rs) in HIV-1-infected intravenous drug users: change in circulating sTNF-R type II level and survival for AIDS patients.

Authors:  F Ajello; R La Licata; M Lodato; F Vitale; F Bonura; R Valenti; M Bruno; N Romano
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

Review 6.  HIV infection and pathogenesis: what about chemokines?

Authors:  R C Gallo; A Garzino-Demo; A L DeVico
Journal:  J Clin Immunol       Date:  1999-09       Impact factor: 8.317

7.  Elevated levels of tumor necrosis factor alpha (TNF-alpha) in human immunodeficiency virus type 1-transgenic mice: prevention of death by antibody to TNF-alpha.

Authors:  Swapan K De; Krishnakumar Devadas; Abner Louis Notkins
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

8.  Gp120 activates children's brain endothelial cells via CD4.

Authors:  M F Stins; Y Shen; S H Huang; F Gilles; V K Kalra; K S Kim
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

9.  Multisite comparison of high-sensitivity multiplex cytokine assays.

Authors:  Elizabeth Crabb Breen; Sandra M Reynolds; Christopher Cox; Lisa P Jacobson; Larry Magpantay; Candice B Mulder; Oliver Dibben; Joseph B Margolick; Jay H Bream; Elise Sambrano; Otoniel Martínez-Maza; Elizabeth Sinclair; Persephone Borrow; Alan L Landay; Charles R Rinaldo; Philip J Norris
Journal:  Clin Vaccine Immunol       Date:  2011-06-22

10.  Lipopolysaccharide-enhanced transcellular transport of HIV-1 across the blood-brain barrier is mediated by the p38 mitogen-activated protein kinase pathway.

Authors:  Shinya Dohgu; William A Banks
Journal:  Exp Neurol       Date:  2008-01-19       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.